This Solicitation opportunity from Department Of Defense was posted on May 10, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
NIRMATRELVIR AND RI
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
This contract solicitation (SPE2DP-26-T-3321) issued by the Department of Defense’s Medical Supply Chain Pharmacy FSA under DLA Troop Support calls for the procurement of Nirmatrelvir and Ritonavir tablets, marketed as Paxlovid. The product consists of blister cards each containing two 150 mg Nirmatrelvir tablets and one 100 mg Ritonavir tablet, packaged to provide a five-day supply with two daily doses per box of 10 blister cards. The contract specifies a shelf life requirement of 36 months, non-extendable, and mandates compliance with FDA regulations. Packaging must adhere to MIL-STD-2073-1E and DLA specific packaging requirements (RP001), including commercial-grade exterior containers capable of withstanding shipment without damage. Marking for medical acquisitions is governed by Medical Marking Standard No. 1, superseding MIL-STD-129, to ensure proper identification. Delivery is FOB destination with a required delivery timeline of five days after order, shipping to the USS Rafael Peralta DDG 115 located at FPO AP 96694-1500. Inspection and acceptance occur at destination. The contract incorporates multiple FAR and DFARS clauses addressing key compliance areas such as equal opportunity for workers with disabilities, combating trafficking in persons, employment eligibility verification, sustainable products usage, hazardous materials identification and labeling, and control of sensitive defense information. Cybersecurity requirements are emphasized, incorporating clauses related to safeguarding covered defense information as per NIST SP 800-171 and DoD mandates. Contractors must use electronic invoicing and payment systems via WAWF, ensuring timely and accurate submission of invoices and receiving reports. Representations and certifications required from offerors include entity identification, socioeconomic status, and compliance with acquisition regulations, all to be provided through the System for Award Management (SAM). Proposal submissions are due by May 18, 2026, via the DLA Internet Bid Board System (DIBBS), with specific instructions for packaging, marking, delivery, and hazardous material handling fully outlined to ensure conformity with DoD and FDA standards.
General Info
Agency
NAICS
Place of Performance
UNIT 100415 BOX 1, FPO, AP, 96694-1500, USSet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
NIRMATRELVIR AND RITONAVIR TABLETS
PAXLOVIDNIRMATRELVIR 300 GM RITONAVIR
100 MG. 10 BLISTER CARDS. EACH BLISTER
CARD CONTAINS 3 TABLETS: 2 NIRMATRELVIR
TABLETS (150 MG EACH) 1 RITONAVIR TABLET
(100 MG EACH). EACH BLISTER CARD CONTAINS
ONE DOSE (MUST TAKE ALL THREE TABLETS).
BOX CONTAINS 5 DAY SUPPLY OF TWO DAILY DOSES.
.
RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
. UNIT OF ISSUE BOX OF 10 EA . RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS (IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
.
BIDDER SHALL SPECIFY SOURCE AND
PART NUMBER BEING SUPPLIED.
.
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. .
PFIZER INC 86491 P/N NDC00069-5321-30
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016699404 0001 BX 2.000
SPE2DP-26-T-3321
SECTION B
PR: 7016699404 PRLI: 0001 CONT’D
NSN/MATERIAL:6505017227590
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
QUP:001 PRES MTHD:ZZ CLNG/DRY:Z PRESV MAT:ZZ
WRAP MAT:ZZ CUSH/DUNN MAT:ZZ CUSH/DUNN THKNESS:Z
UNIT CONT:ZZ OPI:M
INTRMDTE CONT:ZZ INTRMDTE CONT QTY:ZZZ
PACK CODE:U
MARKING SHALL BE IN ACCORDANCE WITH MIL-STD-129.
SPECIAL MARKING CODE:ZZ -ZZ Special Requirements
PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
PARCEL POST ADDRESS:
R50126
USS RAFAEL PERALTA DDG 115
UNIT 100415 BOX 1
FPO AP 96694-1500
US
SPE2DP-26-T-3321
SECTION B
PR: 7016699404 PRLI: 0001 CONT’D
VESSEL SHIPMENT. TRANSPORTATION SEE DLAD PROC NOTE C19. FIRST DESTINATION TRANSPORTATION SEE DLAD PROC
NOTE C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
R50126
USS RAFAEL PERALTA DDG 115
DLA VENDORS: USE VSM FOR
US
RDD 999/NMCS SHIPMENT. TRANSPORTATION SEE DLAD PROC NOTE C19. FIRST DESTINATION TRANS SEE DLAD PROC NOTE
C20 AND CONTRACT
M/F: (TCN) R501266127HM30
RDD: 999
PROJ: EP5 TP 1
SUPP ADD: YHM01 SIG: A
FOR GOVERNMENT USE ONLY: (IPD) 02
DIC: A41 DIST: 9B ADV: 2A FC: N7
Need Ship Date:00/00/0000 Original Required Delivery Date:05/12/2026
SPE2DP-26-T-3321 NSN/Part Number: 6505-01-722-7590 Quantity: 2 BX Purchase Request: 7016699404QTY: 2 Delivery: 5 days ADO
